Guilford halts Gliatech deal
Article Abstract:
Baltimore, MD-based Guilford Pharmaceuticals scratched plans to acquire Cleveland, OH-based Gliatech. The move was motivated by the FDA's questioning of irregularities in Gliaaatech's clinical trial data of its anti-scarring gel.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Guilford acquires Gliatech in strategic deal
Article Abstract:
Guildford Pharmaceuticals has reached an agreement to purchase Gliatech, a biotechnology company. Guildford is acquiring Gliatech for approximately $203 million in shares.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Monsanto to merge with P&U
Article Abstract:
Article discussing how Monsanto has agreed to merge with Pharmacia and Upjohn (P&U). Monsanto will give up its agricultural unit.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: A service effort allocation model for assessing customer lifetime value in service marketing. After-service response in service quality assessment: real time updating model approach
- Abstracts: Life's a switch and then you buy. Be a better investor. Stop-losses, do they work?
- Abstracts: Stocking fillers with a future. Life with the dogs. What's hot?
- Abstracts: Why Footsie isn't listening. UK equities: a tough year. Phone fun
- Abstracts: Trehalose expression confers desiccation tolerance on human cells. Measuring the peptides in individual organelles with mass spectrometry